Health Insight: Feb 16, 2026
Mounjaro and Ozempic: The Weight-Loss Wonder Drugs of 2026? The medical and wellness worlds are abuzz with the remarkable weight-loss and metabolic benefits of GLP-1 receptor agonists, particularly Ozempic (semaglutide) and Mounjaro (tirzepatide). These injectable medications, originally developed for type 2 diabetes management, have transitioned into a dominant force in the obesity and weight management …